A novel evaluation of genetic polymorphism in BCG adenitis

Bacillus Calmette-Guerin (BCG) is a live attenuated vaccine which has been used to prevent tuberculosis, according to the World Health Organization (WHO) recommendation in parts of the world with an incidence of tuberculosis infection more than 1%. The incidence of BCG adverse reactions differs bet...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Hassanzad, Poupak Farnia, Sepideh Darougar, Ali Akbar Velayati
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2019-06-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/722
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042938030030848
author Maryam Hassanzad
Poupak Farnia
Sepideh Darougar
Ali Akbar Velayati
author_facet Maryam Hassanzad
Poupak Farnia
Sepideh Darougar
Ali Akbar Velayati
author_sort Maryam Hassanzad
collection DOAJ
description Bacillus Calmette-Guerin (BCG) is a live attenuated vaccine which has been used to prevent tuberculosis, according to the World Health Organization (WHO) recommendation in parts of the world with an incidence of tuberculosis infection more than 1%. The incidence of BCG adverse reactions differs between regions with regional lymphadenitis as the most common presentation. The aim of this study was to detect the impact of polymorphisms causing BCG lymphadenitis in children receiving BCG vaccination at birth. Eight healthy infants with BCG adenitis from 4 to 12 months old were enrolled. All these patients underwent a thorough physical examination, abdominopelvic ultrasound evaluation to detect distant lymphadenopathies and immunodeficiency screening tests for any possible underlying immunodeficiency disorders. Then genotyping for known mutations was performed using restriction fragments length polymorphism (PCR-RFLP) assays. Sequencing was performed for IL-12 Rβ1, IFN-ϒ receptor 1, IL-10, TNF-α and P2X7. The mean age of onset of the adenitis was 6.5 months. TNF-857, IL-12Rβ1 705, IL-10 1082, and IFN-ϒ- 56 single nucleotide polymorphisms (SNPs) were common in the children studied. The most frequent polymorphism found in the patients with BCG adenitis except one, was the P2X7 -762 polymorphism. To conclude, these polymorphisms are more common in some ethnic populations but not others and make the genetic basis of immunity to BCG strains and the occurrence of post-BCG lymphadenitis in otherwise healthy children.
format Article
id doaj-art-2f29c056029b4e5cb813723faee729a2
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2019-06-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-2f29c056029b4e5cb813723faee729a22025-08-20T02:55:21ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212019-06-0161310.24953/turkjped.2019.03.026A novel evaluation of genetic polymorphism in BCG adenitisMaryam Hassanzad0Poupak FarniaSepideh Darougar1Ali Akbar Velayati2Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran.Department of Pediatrics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran. Bacillus Calmette-Guerin (BCG) is a live attenuated vaccine which has been used to prevent tuberculosis, according to the World Health Organization (WHO) recommendation in parts of the world with an incidence of tuberculosis infection more than 1%. The incidence of BCG adverse reactions differs between regions with regional lymphadenitis as the most common presentation. The aim of this study was to detect the impact of polymorphisms causing BCG lymphadenitis in children receiving BCG vaccination at birth. Eight healthy infants with BCG adenitis from 4 to 12 months old were enrolled. All these patients underwent a thorough physical examination, abdominopelvic ultrasound evaluation to detect distant lymphadenopathies and immunodeficiency screening tests for any possible underlying immunodeficiency disorders. Then genotyping for known mutations was performed using restriction fragments length polymorphism (PCR-RFLP) assays. Sequencing was performed for IL-12 Rβ1, IFN-ϒ receptor 1, IL-10, TNF-α and P2X7. The mean age of onset of the adenitis was 6.5 months. TNF-857, IL-12Rβ1 705, IL-10 1082, and IFN-ϒ- 56 single nucleotide polymorphisms (SNPs) were common in the children studied. The most frequent polymorphism found in the patients with BCG adenitis except one, was the P2X7 -762 polymorphism. To conclude, these polymorphisms are more common in some ethnic populations but not others and make the genetic basis of immunity to BCG strains and the occurrence of post-BCG lymphadenitis in otherwise healthy children. https://turkjpediatr.org/article/view/722BCGadenitisgeneticimmunizationpolymorphism
spellingShingle Maryam Hassanzad
Poupak Farnia
Sepideh Darougar
Ali Akbar Velayati
A novel evaluation of genetic polymorphism in BCG adenitis
The Turkish Journal of Pediatrics
BCG
adenitis
genetic
immunization
polymorphism
title A novel evaluation of genetic polymorphism in BCG adenitis
title_full A novel evaluation of genetic polymorphism in BCG adenitis
title_fullStr A novel evaluation of genetic polymorphism in BCG adenitis
title_full_unstemmed A novel evaluation of genetic polymorphism in BCG adenitis
title_short A novel evaluation of genetic polymorphism in BCG adenitis
title_sort novel evaluation of genetic polymorphism in bcg adenitis
topic BCG
adenitis
genetic
immunization
polymorphism
url https://turkjpediatr.org/article/view/722
work_keys_str_mv AT maryamhassanzad anovelevaluationofgeneticpolymorphisminbcgadenitis
AT poupakfarnia anovelevaluationofgeneticpolymorphisminbcgadenitis
AT sepidehdarougar anovelevaluationofgeneticpolymorphisminbcgadenitis
AT aliakbarvelayati anovelevaluationofgeneticpolymorphisminbcgadenitis
AT maryamhassanzad novelevaluationofgeneticpolymorphisminbcgadenitis
AT poupakfarnia novelevaluationofgeneticpolymorphisminbcgadenitis
AT sepidehdarougar novelevaluationofgeneticpolymorphisminbcgadenitis
AT aliakbarvelayati novelevaluationofgeneticpolymorphisminbcgadenitis